Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00040326 · ClinicalTrials.gov registry record · Phase 3
Early Surgical Intervention to Treat Epilepsy
A Phase 3 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
NCT00040326 is a Phase 3 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 200 participants.
The verdict
NCT00040326, a Phase 3 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this trial is to compare the effectiveness of early surgical intervention for mesial temporal lobe epilepsy to continued treatment with antiepileptic drugs.
Interventions
- PROCEDURE anteromesial temporal resection
- DRUG antiepileptic drugs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-07 |
| Est. Completion | 2007-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00040326
The ClinicalTrials.gov registry entry for NCT00040326 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which anteromesial temporal resection is the first listed.
NCT00040326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00040326 about?
NCT00040326 is a clinical study titled "Early Surgical Intervention to Treat Epilepsy". The purpose of this trial is to compare the effectiveness of early surgical intervention for mesial temporal lobe epilepsy to continued treatment with antiepileptic drugs.
What is the current status of trial NCT00040326?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2002-07. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00040326?
The interventions under investigation include: anteromesial temporal resection (PROCEDURE), antiepileptic drugs (DRUG).
Who is sponsoring clinical trial NCT00040326?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.